Stocklytics Platform
Asset logo for symbol TMO
Thermo Fisher Scientific
TMO54
$512.84arrow_drop_up0.70%$3.61
S&P500
Asset logo for symbol TMO
TMO54

$512.84

arrow_drop_up0.70%

Performance History

Chart placeholder
Key Stats
Open$507.08
Prev. Close$509.12
EPS15.94
Next Earnings DateJan 15, 2025
LOWHIGH
Day Range504.41
524.44
52 Week Range415.60
627.88
Ratios
EPS15.94

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science. The company offers a comprehensive range of products and services, including analytical instruments, reagents, consumables, software, and services for research, analysis, discovery, and diagnostics. With a mission to enable customers to make the world healthier, cleaner, and safer, Thermo Fisher Scientific is committed to advancing scientific knowledge and improving human health. The company operates in four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher Scientific has a strong financial position and impressive growth trajectory, with consistent revenue and earnings growth over the years. The company has a market cap of over $200 billion and has consistently outperformed the broader industry. Thermo Fisher Scientific's stock price has seen substantial growth and is currently trading near its 52-week high range. The company's PEG ratio indicates a favorable valuation, suggesting that the stock may be undervalued compared to its earnings growth potential.
Websitecall_made
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Marc N. Casper
Headquarters
Waltham
Employees
130000
Exchange
NYSE
add Thermo Fisher Scientific to watchlist

Keep an eye on Thermo Fisher Scientific

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Thermo Fisher Scientific 's (TMO) price per share?

The current price per share for Thermo Fisher Scientific (TMO) is $512.84. The stock has seen a price change of $3.61 recently, indicating a 0.71% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Thermo Fisher Scientific (TMO)?

For Thermo Fisher Scientific (TMO), the 52-week high is $627.88, which is 22.43% from the current price. The 52-week low is $415.6, the current price is 23.4% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Thermo Fisher Scientific (TMO) a growth stock?

Thermo Fisher Scientific (TMO) has shown an average price growth of -7.34% over the past three years. It has received a score of 38 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Thermo Fisher Scientific as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Thermo Fisher Scientific (TMO) stock price performance year to date (YTD)?

As of the latest data, Thermo Fisher Scientific (TMO) has a year-to-date price change of -5.75%. Over the past month, the stock has experienced a price change of -13.86%. Over the last three months, the change has been -16.55%. Over the past six months, the figure is -13.66%. Looking at a longer horizon, the five-year price change stands at 66.87%.
help

Is Thermo Fisher Scientific (TMO) a profitable company?

Thermo Fisher Scientific (TMO) has a net income of $6B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 40.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.06% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $42.86B, although specific revenue growth data is currently not available. The gross profit is $17.56B. Operating income is noted at $6.86B. Furthermore, the EBITDA is $11.74B.
help

What is the market capitalization of Thermo Fisher Scientific (TMO)?

Thermo Fisher Scientific (TMO) has a market capitalization of $196.16B. The average daily trading volume is 511.22, indicating the stock's liquidity and investor engagement.

News

[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
APHERESIS EQUIPMENT
CHRONIC DISEASES
TECHNOLOGICAL ADVANCEMENTS
BLOOD COMPONENTS
Nov 21, 2024

[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Bioprocess Validation Market to Witness 9.10% CAGR by 2031 | SkyQuest Technology
BIOPROCESS VALIDATION
BIOPHARMACEUTICALS
BIOLOGICS
BIOMANUFACTURING
Nov 19, 2024

Bioprocess Validation Market to Witness 9.10% CAGR by 2031 | SkyQuest Technology

Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - SNS Insider
PROTEIN ENGINEERING
BIOTECHNOLOGY
PERSONALIZED MEDICINE
INDUSTRIAL APPLICATIONS
Nov 18, 2024

Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - SNS Insider

DNA Synthesis Market to Reach USD 15.48 Billion by 2032 Driven by Demand for Genomics Research and Personalized Medicine
DNA SYNTHESIS
GENOMICS
PERSONALIZED MEDICINE
THERAPEUTICS
RESEARCH AND DEVELOPMENT
Nov 15, 2024

DNA Synthesis Market to Reach USD 15.48 Billion by 2032 Driven by Demand for Genomics Research and Personalized Medicine

Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58%
PHARMACEUTICAL STERILITY TESTING
MARKET GROWTH
TECHNOLOGICAL ADVANCEMENTS
BIOPHARMACEUTICALS
REGULATORY COMPLIANCE
Nov 15, 2024

Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58%

DNA Synthesis Market Analysis and Forecast, 2024-2028 - Rising Investments in Genomics R&D and Advances in Sequencing Technologies Driving the Industry at 18.1% CAGR
DNA SYNTHESIS
GENOMICS
SEQUENCING
THERAPEUTICS
PCR
Nov 15, 2024

DNA Synthesis Market Analysis and Forecast, 2024-2028 - Rising Investments in Genomics R&D and Advances in Sequencing Technologies Driving the Industry at 18.1% CAGR

Take Your Investments to a Whole New Level